Our future-forward, fully self-sufficient Quality Control (QC) laboratory operates 24/7 to monitor, test, and validate every phase of the manufacturing cycle. Equipped with advanced analytical instrumentation, our in-house lab eliminates reliance on third parties, ensuring absolute data integrity, accelerated turnaround times, and total confidentiality.
Equipped with advanced UV/Vis and Photo-Diode Array (PDA) detectors for ultra-precise assay determination, impurity profiling, and active ingredient quantification.
Utilizing advanced headspace samplers to detect, isolate, and quantify volatile organic compounds and residual solvents with extreme sensitivity.
For rapid qualitative testing, identification, and routine concentration analysis of raw materials and finished products.
Providing definitive molecular fingerprinting to verify the identity and authenticity of incoming raw materials.
Simulating human physiological conditions to ensure precise, batch-to-batch drug release kinetics for our solid dosages.
Simulating diverse global climate zones (Real-Time and Accelerated) to guarantee product shelf-life and molecular stability over time.
Our Commitment
At Kimaayra Pharma, our operational philosophy is anchored in clinical excellence, data integrity, and uncompromised biosafety. We continuously invest in advanced automation, human capital, and forward-looking technologies to ensure every therapeutic batch satisfies the most demanding international validation frameworks.
The Standard: Architectural design and environmental controls built in strict compliance with cGMP, WHO-GMP, and PIC/S frameworks.
The Protocol: Advanced HVAC zoning, automated water loops, and unidirectional logistics flows designed to completely eliminate cross-contamination.
The Standard: End-to-end lifecycle validation following ALCOA+ data integrity regulations.
The Protocol: Rigorous raw material fingerprinting via in-house HPLC/GC, strict batch manufacturing records (BMR), and 100% complete batch traceability.
The Standard: A highly trained technical workforce operating within an autonomous, decentralized culture of quality.
The Protocol: Documented, continuous cGMP training modules for all operators, managed by an independent Quality Assurance team with absolute veto authority.
The Standard: Proactive system enhancements driven by ICH Q9 Quality Risk Management principles.
The Protocol: Direct integration of real-time automated process monitoring (PAT) and a scientifically driven CAPA framework to permanently eliminate manufacturing variances.
Our end-to-end workflow transforms raw molecules into high-efficacy, patient-ready therapies. Every phase is operationally synchronized with strict WHO-GMP and global cGMP standards.
We scientifically engineer active ingredients with advanced excipient matrices to ensure maximum stability. This critical phase guarantees optimal drug dissolution and maximum therapeutic absorption within the body.
Our state-of-the-art automated lines execute high-throughput production with minimal manual intervention. Every batch is continuously monitored by automated feedback loops to guarantee perfect content uniformity.
Our high-tech in-house laboratory subjects every batch to rigorous chemical and microbiological validation. Utilizing advanced HPLC and GC instrumentation, we ensure 100% safety and purity before release.
Products are hermetically sealed using high-speed automated lines and multi-layered barrier laminates. Our secure logistics framework provides complete batch traceability and transparency across the global supply chain.